Monday, January 04, 2021 10:14:20 AM
This past year involved a pandemic which led to a large decline in sales, reduction in staff, and a lot of dilution in the stock to raise funds to keep the business afloat.
However, with the last funding raised before end of the year, we should see a lot less volume for selling the stock and more buying demand as sales start coming in. They mentioned the need to ramp up the sales team and this doesn't happen unless they are predicting massive growth. Based on the numbers they shared, I'd estimate that they are expecting a large increase in AI sales.
One thing is for certain IMO, we will see the sell off begin to flip into large purchases since this is fairly undervalued based on the growth model I'm predating. I based this model off of similar startups in their space and Y/Y growth.
Cheers to a better 2021.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM